Alleged Scoop Sours Magnetoreceptor Collaboration

University administrators request a retraction upon learning that one researcher scooped another’s results despite having agreed not to.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, GERALTAdministrators at two universities in China are asking a journal to retract a study in which researchers reported controlling cells using a magnetic receptor. As Nature News reported today (September 21), the investigator who first discovered the receptor—and has a paper in press about it— is alleging that his colleague used his data and the protein to publish a paper this month, violating their agreement to wait until the paper describing the receptor came out.

“I never really worried about it because we all agreed that the paper determining the protein should be first,” Xie Can, a biophysicist at Peking University, told Nature News.

Xie cried foul about a publication by Zhang Sheng-jia, a neuroscientist at Tsinghua University in Beijing. Zhang’s work, published September 14 in Science Bulletin, describes a method of expressing the magnetoreceptor in cultured cells and applying a magnetic field to control cellular activity. “We envision a new age of magnetogenetics is coming,” Zhang and his colleagues wrote in their report.

Xie said that he was willing to share the receptor with Zhang, under the condition that Xie’s paper would take precedence. Zhang countered that Xie had agreed not to share the receptor with anyone else, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies